drugset / Trial / NCT05156541
Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the effectiveness of destructive therapy for anogenital warts in combination with the use of Ingaron in comparison with destructive therapy.
Timeline
- Start
- 2009-05-18
- Primary completion
- 2010-06-30
- Completion
- 2010-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interferon gamma | Protein / enzyme biologic | 100000 iu | — |